| Suresh Nukala, MD | |
|
1414 W Fair Ave Ste 332, Marquette, MI 49855-5407 | |
| (906) 225-3922 | |
| (906) 225-4527 |
| Full Name | Suresh Nukala |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 31 Years |
| Location | 1414 W Fair Ave Ste 332, Marquette, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578643037 | NPI | - | NPPES |
| P00365530 | Other | MI | RAILROAD MEDICARE |
| 4940237 | Medicaid | MI | |
| SN089054 | Other | MI | BCBSM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 4301089054 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Columbus Regional Midtown | Columbus, GA | Hospital |
| Piedmont Columbus Regional Northside | Columbus, GA | Hospital |
| St Francis Hospital- Emory Healthcare | Columbus, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Medical Center, Inc. | 9830094077 | 21 |
News Archive
According to a new report by iData Research, the leading global authority in medical device market research, the Chinese and Indian markets for hearing devices, including retail and wholesale sales, is valued at over $1 billion and will almost double-in-value by 2017.
Oncotarget published "Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations" which reported that unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients.
New research suggests that highly mobile, expressive eyebrows may have been key to helping humans form social bonds and cooperating with each other as part of their survival.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) has issued final draft guidance indicating that ILUVIEN is not recommended for the treatment of chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 4 days ago
| Entity Name | The Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255401519 PECOS PAC ID: 9830094077 Enrollment ID: O20040630000391 |
News Archive
According to a new report by iData Research, the leading global authority in medical device market research, the Chinese and Indian markets for hearing devices, including retail and wholesale sales, is valued at over $1 billion and will almost double-in-value by 2017.
Oncotarget published "Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations" which reported that unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients.
New research suggests that highly mobile, expressive eyebrows may have been key to helping humans form social bonds and cooperating with each other as part of their survival.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) has issued final draft guidance indicating that ILUVIEN is not recommended for the treatment of chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Suresh Nukala, MD 4602 Dept, Carol Stream, IL 60122-0021 Ph: (906) 225-3922 | Suresh Nukala, MD 1414 W Fair Ave Ste 332, Marquette, MI 49855-5407 Ph: (906) 225-3922 |
News Archive
According to a new report by iData Research, the leading global authority in medical device market research, the Chinese and Indian markets for hearing devices, including retail and wholesale sales, is valued at over $1 billion and will almost double-in-value by 2017.
Oncotarget published "Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations" which reported that unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients.
New research suggests that highly mobile, expressive eyebrows may have been key to helping humans form social bonds and cooperating with each other as part of their survival.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) has issued final draft guidance indicating that ILUVIEN is not recommended for the treatment of chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 4 days ago
Dr. Robert John Carroll, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 850 W Baraga Ave, Marquette, MI 49855 Phone: 906-449-3000 | |
Kenneth Buran, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 850 W Baraga Ave Ste 32, Marquette, MI 49855 Phone: 906-449-3680 Fax: 833-916-2211 | |
Nelson Eric Gencheff, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1414 West Fair Avenue, Suite 334, Marquette, MI 49855 Phone: 906-225-3870 Fax: 906-225-4861 | |
Kaitlyn Marie Joyce, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1414 W Fair Ave Ste 201, Marquette, MI 49855 Phone: 906-225-4500 Fax: 906-225-3919 | |
John Michael Pap, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1414 West Fair Avenue, Suite 334, Marquette, MI 49855 Phone: 906-225-3870 Fax: 906-225-4861 | |
Mr. Daniel J Arnold, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1414 W Fair Ave, Suite 332, Marquette, MI 49855 Phone: 906-225-3922 Fax: 906-225-4527 | |
Jasmine Joseph, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1414 W Fair Ave, Ste 344, Marquette, MI 49855 Phone: 906-225-3910 Fax: 906-225-4529 |